The December version of our Most Attractive Stocks report is now available. Note that Barron’s recently recognized our Most Attractive Stocks portfolio as #1 over the prior 12 months amongst the best of the Wall Street research firms.
Lots of tech and pharma stocks make this month’s list. For example, Microsoft (MSFT) and Analog Devices (ADI) make the cut for the large cap Most Attractive this month. We also like China Biotics (CHBT) , Safe Bulkers (SB) and Surmodics (SRDX) on the small cap list. All of these stocks get our “very attractive” rating, which mean they have high quality economic earnings and their valuations are cheap. For example, the current stock prices of MSFT and ADI imply those companies profits will decline permanently by 10% or more. The current stock prices of CHBT, SB and SRDX imply those companies profits will decline permanently by 50% or more. The low expectations in the stock prices of these stocks provide investors attractive downside protection and upside potential.
Note that we offer free company valuation reports for 4 of the companies included in our Most Attractive and Most Dangerous Stocks newsletters.
Here is a quick overview for the December reports.
- 7 new stocks make our December lists.
- The Most Attractive Stocks portfolio (-1.2%) outperformed the S&P 500 (-1.5%) last month.
- Most Attractive Stocks have high and rising returns on capital (ROIC) and low market expectations for future profits.